OraPharma Inc. (acquired by JNJ)
Bridgewater, New Jersey, United States
About OraPharma Inc. (acquired by JNJ)
OraPharma is a specialty pharmaceutical company that develops and commercializes products that help improve and maintain oral health. They are dedicated to delivering scientifically and technologically advanced products to dental professionals and their practices. ARESTIN® (minocycline HCl) Microspheres, 1 mg is a locally administered antibiotic (LAA) offering a patented microsphere technology. OraPharma is proud to have introduced this revolutionary approach to treating periodontitis as an adjunct to scaling and root planing and continues to take a leadership role in educating clinicians and consumers on the disease. Read more about ARESTIN® or click here for Prescribing Information.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $16.0M
- Last round: Series Unknown (Dec 1998)
- Website: orapharma.com
- Phone: 1(866)273-7846
Industries & Categories
Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/orapharma-inc-acquired-by-jnj-2539649 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.